[Optimization of treatment options through a multidisciplinary approach for advanced hormone refractory prostate carcinoma]

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Docetaxel
• Drug Resistance, Neoplasm
• Humans
• Male
• Mitoxantrone / therapeutic use
• Prednisone / therapeutic use
• Prostatic Neoplasms / mortality
• Prostatic Neoplasms / therapy*
• Taxoids / therapeutic use
• Treatment Failure